20.10 (-%)
As of Oct 31, 2024
Source:
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy, a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs.
Country | United States |
Headquarters | san diego, california |
Phone Number | ( 858 ) 727-1755 |
Industry | manufacturing |
CEO | Linda Marb |
Website | www.capricor.com |